Adenocarcinoma — Research

Adenocarcinoma — Research · CancerIndex

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

pubmedComputed3 windows · counts computed by CancerIndex from PubMed E-utilities; the exact query is stored with each count.

Window	Period	Records (count)	Exact query	Computed	Source
All time	… → 2026-09-11	490,877	`("Adenocarcinoma"[mh] OR "Adenocarcinomas"[mh] OR "Adenoma, Malignant"[mh] OR "Adenomas, Malignant"[mh])`	2026-09-11	pubmed
Last 5 years	2021-01-01 → 2026-12-31	93,894	`("Adenocarcinoma"[mh] OR "Adenocarcinomas"[mh] OR "Adenoma, Malignant"[mh] OR "Adenomas, Malignant"[mh]) AND (2021/01/01:2026/12/31[dp])`	2026-09-11	pubmed
Last 12 months	2025-09-11 → 2026-09-11	15,455	`("Adenocarcinoma"[mh] OR "Adenocarcinomas"[mh] OR "Adenoma, Malignant"[mh] OR "Adenomas, Malignant"[mh]) AND (2025/09/11:2026/09/11[dp])`	2026-09-11	pubmed

Data updated 20 days agoSource updated unknownsource: pubmed E-utilities

Literature

Linked publications (378)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedPublishedShowing 126–150 of 378 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

Analysis of clinicopathologic features and expression of NR4A3 in sinonasal acinic cell carcinoma.
· Mod Pathol · 2022 · PMID 34873305 · validated civic_curation pubmed
LRP1B mutation is associated with tumor immune microenvironment and progression-free survival in lung adenocarcinoma treated with immune checkpoint inhibitors.
· Transl Lung Cancer Res · 2023 · PMID 37057124 · validated civic_curation pubmed
Potential Resistance to Oxaliplatin-Based Regimens in Gastric Cancer Patients with ERBB2 R678Q Mutation: Evidence from a National Genomic Database.
· Curr Issues Mol Biol · 2025 · PMID 40699829 · validated civic_curation pubmed
Cyclin-Dependent Kinase 4/6 Inhibition as a Novel Therapy for Peritoneal Mucinous Carcinomatosis With GNAS Mutations.